What we run
Two assays, three analytes. Stated plainly so you know exactly what a Riftline report does and does not establish.
The assays
The proportion of the sample attributable to the target peptide, reported as area percent, alongside a table of the impurity and degradation peaks observed.
That the main component is the peptide it claims to be — expected mass against measured mass. Purity alone never establishes this, which is why the two run together.
The catalog
| Analyte | Class |
|---|---|
| Retatrutide | GLP-1 / GIP / glucagon receptor agonist |
| Tirzepatide | GLP-1 / GIP receptor agonist |
| Semaglutide | GLP-1 receptor agonist |
What is on the report
Rather than describe it, here is the actual format of every certificate we issue — including the verification block your customers will use. Result fields on the specimen describe what appears there; we don't print numbers from a run that didn't happen.
Your results are yours
What we don't claim
Results relate only to the sample as submitted. We test what arrives in the vial — we do not inspect your facility, audit your supplier, or certify a lot we did not receive. Sterility, endotoxin, residual solvents, and elemental impurities are outside the stated scope and are not implied by a purity and identity report.